Exploring how Adverse Childhood Experiences (ACEs) biologically embed themselves and increase cancer risk through inflammation, epigenetics, and stress response dysregulation.
How the 2011 Fritz Bender Symposium revolutionized personalized cancer medicine through genomic technologies and clinical oncology breakthroughs.
Exploring NMR-based metabolomics as a revolutionary approach to early diagnosis of neurodegenerative diseases through metabolic biomarkers.
Phase I clinical trial results of recombinant oncotoxin TP4O for treating superficial bladder cancer, showing promising safety and efficacy data.
Discover how DNA vaccines are revolutionizing cancer treatment by reprogramming the immune system to target HER-2-driven breast cancer through innovative B7 molecule targeting.
Exploring the rise of young-onset colorectal cancer, its molecular drivers, breakthrough treatments, and prevention strategies.
Exploring cantharidin's journey from ancient poison to modern cancer therapy through global research trends and scientific breakthroughs.
A comprehensive look at how chemotherapy affects cancer survivors' physical and cognitive functions, accelerating aging processes based on the latest research.
Exploring the molecular machinery of nucleosides, nucleotides, and nucleic acids that form the basis of life and modern biotechnology.
How implantable radio-telemetry devices transformed hypertension research by enabling continuous, stress-free blood pressure monitoring in animal models.